Overview
Xenotransplantation is the transfer of living biological material from one species to another. The word derives from the Greek xenos (foreign) and relates to the broader concept of transplantation. In practice it includes grafts of cells, tissues or organs taken from an animal donor and implanted into a human recipient, with the aim of treating organ failure, endocrine disorders, or tissue loss.
Characteristics and technical challenges
Biological incompatibility is the main barrier. The human immune system recognizes foreign antigens and may mount rapid responses such as hyperacute rejection, delayed antibody‑mediated rejection, or cellular rejection. Other technical issues include differences in organ size and physiology, blood clotting and biochemical signaling, and the risk of transferring animal microbes.
Donor species and scientific advances
Pigs are currently the most widely studied donor species because their organs are similar in size and physiology to human organs and they breed relatively quickly. Advances in genetic engineering — including targeted gene editing — aim to reduce immune recognition and improve compatibility. Researchers also develop protocols for immunosuppression, organ perfusion and sterilization to improve graft survival.
History, regulation and research status
Interest in cross‑species grafting dates back many decades and has progressed from laboratory studies in small animals to larger preclinical experiments. Due to complex safety and ethical issues, regulatory authorities require careful infectious‑disease screening, long‑term follow up, and staged clinical testing before broader use. Clinical research focuses on a few organ types and highly regulated trials.
Uses, examples and potential importance
Xenotransplantation could expand the supply of kidneys, hearts, islets for diabetes, skin grafts and other tissues when human donors are scarce. Experimental or compassionate‑use procedures have targeted life‑threatening organ failure and are accompanied by intensive monitoring and specialized care.
Ethical, public‑health and societal considerations
Ethical concerns include animal welfare, informed consent, equitable access, and the prospect of new zoonotic infections. Public health safeguards are designed to limit transmission risks and to monitor recipients and close contacts. Ongoing dialogue among clinicians, regulators, ethicists and the public shapes policy and research priorities.
- Common target organs: heart, kidney, liver, pancreatic islets.
- Key scientific goals: reduce rejection, prevent infection, improve longevity of grafts.
- Related topics: organ donation policy, genetic modification of donor animals.
For introductory resources, readers can follow clinical trial summaries and regulatory guidance from health authorities and specialist reviews of the field. More technical details are available in current scientific literature and expert reports.
Further reading on species considerations and reviews can provide deeper context on risks and progress.